Phase I study of OSI-906, dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) in combination with erlotinib (E) in patients with advanced solid tumors.

被引：4
|
作者：
Macaulay, V. M.
Middleton, M. R.
Eckhardt, S. G.
Juergens, R. A.
Rudin, C. M.
Manukyants, A.
Gogov, S.
Poondru, S.
Gedrich, R.
Gadgeel, S. M.
机构：
[1] Univ Oxford, Oxford, England
[2] Oxford Radcliffe Hosp, Oxford, England
[3] Univ Colorado, Sch Med, Aurora, CO USA
[4] Johns Hopkins Univ, Baltimore, MD USA
[5] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[6] OSI Pharmaceut, Oxford, England
[7] Astellas Pharma, Boulder, CO USA
[8] OSI Pharmaceut, Boulder, CO USA
[9] Karmanos Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.3098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3098
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer
    Singh, Pushpendra
    Alex, Jimi Marin
    Bast, Felix
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [32] Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: A novel approach for overcoming resistance in anticancer treatment
    Tandon, Ruchi
    Kapoor, Shweta
    Vali, Shireen
    Senthil, V.
    Nithya, D.
    Venkataramanan, R.
    Sharma, Ashish
    Talwadkar, Anay
    Ray, Abhijit
    Bhatnagar, Pradip K.
    Dastidar, Sunanda G.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 667 (1-3) : 56 - 65
  • [33] A phase I study of the anti-insulin like growth factor type 1 receptor (IGF-1R) antibody dalotuzumab in pediatric patients with advanced solid tumors
    Frappaz, Didier
    McGregor, Lisa M.
    Pearson, Andrew Dj
    Gore, Lia
    DuBois, Steven G.
    Aerts, Isabelle
    Iannone, Robert
    Geschwindt, Ryan
    Van Schanke, Arne
    Wang, Ruixue
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Peled, Nir
    Wynes, Murry W.
    Ikeda, Norihiko
    Ohira, Tatsuo
    Yoshida, Koichi
    Qian, Jin
    Ilouze, Maya
    Brenner, Ronen
    Kato, Yasufumi
    Mascaux, Celine
    Hirsch, Fred R.
    CELLULAR ONCOLOGY, 2013, 36 (04) : 277 - 288
  • [35] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Nir Peled
    Murry W. Wynes
    Norihiko Ikeda
    Tatsuo Ohira
    Koichi Yoshida
    Jin Qian
    Maya Ilouze
    Ronen Brenner
    Yasufumi Kato
    Celine Mascaux
    Fred R. Hirsch
    Cellular Oncology, 2013, 36 : 277 - 288
  • [36] Insulin-Like Growth Factor-1 Receptor (IGF-1R) and Its Inhibition in Non-Functioning Neuroendocrine Tumors
    Sasano, H.
    Iida, S.
    Ono, K.
    Nakamura, Y.
    Miki, Y.
    NEUROENDOCRINOLOGY, 2011, 94 : 10 - 10
  • [37] Insulin Growth Factor 1 Receptor (IGF-1R) Inhibitor, Linsitinib (OSI-906) in Combination with Bortezomib and Dexamethasone Demonstrates Favorable Safety Prolife and Clinical Activity in Patients with Relapsed/Refractory Multiple Myeloma
    Trudel, Suzanne
    White, Darrell
    Gyger, Martin
    Kaufmann, Jonahtan
    Jakubowiak, Andrzej
    Gul, Engin
    Le, Lisa W.
    Li, Zhihua
    Reece, Donna
    Kukreti, Vishal
    LeBlanc, Richard
    BLOOD, 2015, 126 (23)
  • [38] Antisense Oligonucleotide Targeting of Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Prostate Cancer
    Furukawa, Junya
    Wraight, Christopher J.
    Freier, Susan M.
    Peralta, Eigan
    Atley, Lynne M.
    Monia, Brett P.
    Gleave, Martin E.
    Cox, Michael E.
    PROSTATE, 2010, 70 (02): : 206 - 218
  • [39] Targeting the insulin-like growth factor-1 receptor (IGF-1R) in the treatment of metastazising uveal melanoma
    Ericsson, CB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U514 - U514
  • [40] Epidermal insulin receptor (IR) and Insulin like growth factor-1 (IGF-1R) receptor are essential on maintenance epidermal morphogenesis and proliferative potential
    Stachelscheid, H.
    Schmitz, A.
    Bruening, J. C.
    Niessen, C. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S60 - S60
12345